Stephen D. Griffin's Net Worth
$5.02 Million
Who is Stephen D. Griffin?
Stephen D. Griffin has an estimated net worth of $5.02 Million. This is based on reported shares across multiple companies, which include VSE CORP, and Anika Therapeutics, Inc..
SEC CIK
Stephen D. Griffin's CIK is 0001831125
Past Insider Trading and Trends
2023 was Stephen D. Griffin's most active year for acquiring shares with 9 total transactions. Stephen D. Griffin's most active month to acquire stocks was the month of February. 2024 was Stephen D. Griffin's most active year for disposing of shares, totalling 4 transactions. Stephen D. Griffin's most active month to dispose stocks was the month of February. 2023 saw Stephen D. Griffin paying a total of $21,967.98 for 16,015 shares, this is the most they've acquired in one year. In 2024 Stephen D. Griffin cashed out on 7,347 shares for a total of $319,351.92, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
VSE CORP (VSEC) Snapshot price: $83.11
Senior Vice President and CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +10.33% | 2.69K |
$79.02 | -$91,663.20 | 28.76K |
Mar 31 - Apr 1
| |||
Form 4
| +37.27% | 7.08K |
$75.12 | -$227,688.72 | 26.07K |
Mar 8 - Mar 11
| |||
Form 4
| +1.24% | 233 |
$47.12 | $10,977.84 | 18.99K |
Dec 29
| |||
Form 4
| +1.45% | 268 |
$41.01 | $10,990.14 | 18.76K |
Jun 30
| |||
Form 4
| +11.39% | 1.89K |
$44.90 | -$36,548.60 | 18.49K |
Mar 31
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Mar 10
| |||
Form 4
| +15.62% | 2.24K |
$40.98 | -$39,624.25 | 16.6K |
Mar 10 - Mar 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 8
| |||
Form 4
| +0.99% | 141 |
$32.31 | $4,556.22 | 14.36K |
Dec 30
| |||
Form 4
| +32.59% | 3.49K |
$48.54 | -$73,101.24 | 14.22K |
Nov 9
| |||
Form 4
| +3.11% | 323 |
$33.07 | $10,681.74 | 10.72K |
Jun 30
| |||
Form 4
| +21.48% | 1.84K |
$46.09 | -$35,811.93 | 10.4K |
Mar 31
| |||
Form 4
| +0.53% | 45 |
$43.30 | -$822.70 | 8.56K |
Mar 11
| |||
Form 4
| +2.45% | 204 |
$44.04 | $8,984.16 | 8.52K |
Dec 31
| |||
Form 4
| +151.01% | 5K |
—
|
—
| 8.31K |
Nov 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 4
| +1.32% | 43 |
$41.42 | -$994.08 | 3.31K |
Mar 16
| |||
Form 4
|
∞
| 3.27K |
—
|
—
| 3.27K |
Nov 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Anika Therapeutics, Inc. (ANIK) Snapshot price: $24.56
EVP, CFO and Treasurer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||